These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 10356134)

  • 1. Leukocyte adhesion deficiency II syndrome, a generalized defect in fucose metabolism.
    Marquardt T; Brune T; Lühn K; Zimmer KP; Körner C; Fabritz L; van der Werft N; Vormoor J; Freeze HH; Louwen F; Biermann B; Harms E; von Figura K; Vestweber D; Koch HG
    J Pediatr; 1999 Jun; 134(6):681-8. PubMed ID: 10356134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insights into leukocyte adhesion deficiency type 2 from a novel mutation in the GDP-fucose transporter gene.
    Hidalgo A; Ma S; Peired AJ; Weiss LA; Cunningham-Rundles C; Frenette PS
    Blood; 2003 Mar; 101(5):1705-12. PubMed ID: 12406889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leukocyte adhesion deficiency II: therapy and genetic defect.
    Wild MK; Lühn K; Marquardt T; Vestweber D
    Cells Tissues Organs; 2002; 172(3):161-73. PubMed ID: 12476046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discontinuation of fucose therapy in LADII causes rapid loss of selectin ligands and rise of leukocyte counts.
    Lühn K; Marquardt T; Harms E; Vestweber D
    Blood; 2001 Jan; 97(1):330-2. PubMed ID: 11133780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leukocyte Adhesion Deficiency Type II is a generalized defect of de novo GDP-fucose biosynthesis. Endothelial cell fucosylation is not required for neutrophil rolling on human nonlymphoid endothelium.
    Karsan A; Cornejo CJ; Winn RK; Schwartz BR; Way W; Lannir N; Gershoni-Baruch R; Etzioni A; Ochs HD; Harlan JM
    J Clin Invest; 1998 Jun; 101(11):2438-45. PubMed ID: 9616215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correction of leukocyte adhesion deficiency type II with oral fucose.
    Marquardt T; Lühn K; Srikrishna G; Freeze HH; Harms E; Vestweber D
    Blood; 1999 Dec; 94(12):3976-85. PubMed ID: 10590041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leukocyte adhesion deficiency type II.
    Becker DJ; Lowe JB
    Biochim Biophys Acta; 1999 Oct; 1455(2-3):193-204. PubMed ID: 10571012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutrophil adhesion in leukocyte adhesion deficiency syndrome type 2.
    Phillips ML; Schwartz BR; Etzioni A; Bayer R; Ochs HD; Paulson JC; Harlan JM
    J Clin Invest; 1995 Dec; 96(6):2898-906. PubMed ID: 8675661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leukocyte adhesion deficiency II-from A to almost Z.
    Etzioni A; Tonetti M
    Immunol Rev; 2000 Dec; 178():138-47. PubMed ID: 11213799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukocyte adhesion deficiency (LAD) II.
    Etzioni A; Phillips LM; Paulson JC; Harlan JM
    Ciba Found Symp; 1995; 189():51-8; discussion 58-62, 77-8. PubMed ID: 7587637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Golgi nucleotide sugar transport and leukocyte adhesion deficiency II.
    Hirschberg CB
    J Clin Invest; 2001 Jul; 108(1):3-6. PubMed ID: 11435449
    [No Abstract]   [Full Text] [Related]  

  • 12. Core fucosylation of N-linked glycans in leukocyte adhesion deficiency/congenital disorder of glycosylation IIc fibroblasts.
    Sturla L; Fruscione F; Noda K; Miyoshi E; Taniguchi N; Contini P; Tonetti M
    Glycobiology; 2005 Oct; 15(10):924-34. PubMed ID: 15917429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Golgi GDP-fucose transporter-deficient mice mimic congenital disorder of glycosylation IIc/leukocyte adhesion deficiency II.
    Hellbusch CC; Sperandio M; Frommhold D; Yakubenia S; Wild MK; Popovici D; Vestweber D; Gröne HJ; von Figura K; Lübke T; Körner C
    J Biol Chem; 2007 Apr; 282(14):10762-72. PubMed ID: 17276979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased availability of GDP-L-fucose in a patient with LAD II with normal GDP-D-mannose dehydratase and FX protein activities.
    Körner C; Linnebank M; Koch HG; Harms E; von Figura K; Marquardt T
    J Leukoc Biol; 1999 Jul; 66(1):95-8. PubMed ID: 10410995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-function studies on selectin carbohydrate ligands. Modifications to fucose, sialic acid and sulphate as a sialic acid replacement.
    Brandley BK; Kiso M; Abbas S; Nikrad P; Srivasatava O; Foxall C; Oda Y; Hasegawa A
    Glycobiology; 1993 Dec; 3(6):633-41. PubMed ID: 7510548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conditional control of selectin ligand expression and global fucosylation events in mice with a targeted mutation at the FX locus.
    Smith PL; Myers JT; Rogers CE; Zhou L; Petryniak B; Becker DJ; Homeister JW; Lowe JB
    J Cell Biol; 2002 Aug; 158(4):801-15. PubMed ID: 12186857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of fucosylation in leukocyte adhesion deficiency II.
    Vestweber D; Lühn K; Marquardt T; Wild M
    Ernst Schering Res Found Workshop; 2004; (44):53-74. PubMed ID: 14579774
    [No Abstract]   [Full Text] [Related]  

  • 18. Adhesion molecule deficiencies and their clinical significance.
    Etzioni A
    Cell Adhes Commun; 1994 Jul; 2(3):257-60. PubMed ID: 7827963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impairment of the Golgi GDP-L-fucose transport and unresponsiveness to fucose replacement therapy in LAD II patients.
    Sturla L; Puglielli L; Tonetti M; Berninsone P; Hirschberg CB; De Flora A; Etzioni A
    Pediatr Res; 2001 Apr; 49(4):537-42. PubMed ID: 11264438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fucose supplementation in leukocyte adhesion deficiency type II.
    Etzioni A; Tonetti M
    Blood; 2000 Jun; 95(11):3641-3. PubMed ID: 10877554
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.